HJ Science Co., Ltd.

6132.HK

HKSEHealthcareBiotechnology

Open in GoAI

Latest quote

HK$40.64

−HK$0.38 · -0.93%

Aug 24, 11:50 AM HKT

Regular session · HKT · Market data may be delayed.

Company profile

Company website

HJ Science Co., Ltd. is a clinical stage biotech company, which engages in research and development of small molecule drugs for tumors, autoimmune & metabolic system diseases for clinical treatments. It provides drug design, in vivo and in vitro activity evaluation, drug metabolism, synthesis, quality research, formulation development, and scale-up. Its products include HJ787, HJ178 and HJ891. The company was founded by Ji Jianxin on February 20, 2017 and is headquartered in Chengdu, China.

Industry: Biotechnology
Sector: Healthcare
Headquarters: CN
CEO: Jian Xin Ji
Listed since: Jun 23, 2026
Employees: 115

Market position

Day range

Current HK$40.64

HK$40.00HK$41.02

52-week range

Current HK$40.64

HK$30.78HK$82.00

Open: HK$40.90
Previous close: HK$41.02
Volume: 35.6K; 0.06× average
Average volume: 641.66K; Average daily volume
Market cap: 2.99B HKD
Beta: -0.15; Market reference 1
50-day average: HK$40.62; +0.05% above average
200-day average: HK$40.62; +0.05% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM): -14.36×
P/B (TTM): 6.44×
P/S (TTM): 184.84×
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 100.00%
Operating margin: -959.44%
Net margin: -1033.54%

Financial health

Debt / equity: 0.04×

Financial statements

Metric (HKD)	FY2025
Revenue	16.18M HKD
Gross profit	16.18M HKD
Research and development	136.41M HKD
Selling, general, and administrative	35.03M HKD
Operating expenses	171.44M HKD
Depreciation and amortization	2.4M HKD
Operating income	−155.26M HKD
Net income	−167.25M HKD